SHENZHEN NEPTUNUS INTERLONG BIO-TECHNIQUE COMPANY LIMITED (8329) Announces Extraordinary General Meeting and Sales Framework Agreement Proposal

Bulletin Express2025-11-24

Shenzhen Neptunus Interlong Bio-technique Company Limited (8329) has scheduled an extraordinary general meeting (EGM) at 10:00 a.m. on Tuesday, 23 December 2025, to be held at the 24th Floor of Neptunus Yinhe Technology Mansion in Nanshan District, Shenzhen. The meeting aims to review and vote on the new Neptunus Group Sales Framework Agreement dated 30 October 2025 with Shenzhen Neptunus Group Company Limited.

The agreement covers the sale of various self-manufactured or distributed products, including pharmaceutical products, healthcare food, and medical devices. Proposed sales caps for 2026, 2027, and 2028 will be presented for confirmation. The EGM will also consider authorizing a director to finalize and execute any additional documents or amendments related to the agreement.

Interested shareholders, both holders of H shares and domestic shares, may attend and vote during the EGM subject to the applicable proxy and attendance procedures detailed in the official announcement. The final outcome of the proposed agreement and sales caps will be determined based on shareholder votes at the meeting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1125119768?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-24 16:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1125119768","market":"us","top_or_hot":-1,"title":"SHENZHEN NEPTUNUS INTERLONG BIO-TECHNIQUE COMPANY LIMITED (8329) Announces Extraordinary General Meeting and Sales Framework Agreement Proposal","media":"Bulletin Express","content":"<p>Shenzhen Neptunus Interlong Bio-technique Company Limited (8329) has scheduled an extraordinary general meeting (EGM) at 10:00 a.m. on Tuesday, 23 December 2025, to be held at the 24th Floor of Neptunus Yinhe Technology Mansion in Nanshan District, Shenzhen. The meeting aims to review and vote on the new Neptunus Group Sales Framework Agreement dated 30 October 2025 with Shenzhen Neptunus Group Company Limited.</p>\n<p>The agreement covers the sale of various self-manufactured or distributed products, including pharmaceutical products, healthcare food, and medical devices. Proposed sales caps for 2026, 2027, and 2028 will be presented for confirmation. The EGM will also consider authorizing a director to finalize and execute any additional documents or amendments related to the agreement.</p>\n<p>Interested shareholders, both holders of H shares and domestic shares, may attend and vote during the EGM subject to the applicable proxy and attendance procedures detailed in the official announcement. The final outcome of the proposed agreement and sales caps will be determined based on shareholder votes at the meeting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SHENZHEN NEPTUNUS INTERLONG BIO-TECHNIQUE COMPANY LIMITED (8329) Announces Extraordinary General Meeting and Sales Framework Agreement Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSHENZHEN NEPTUNUS INTERLONG BIO-TECHNIQUE COMPANY LIMITED (8329) Announces Extraordinary General Meeting and Sales Framework Agreement Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-24 16:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shenzhen Neptunus Interlong Bio-technique Company Limited (8329) has scheduled an extraordinary general meeting (EGM) at 10:00 a.m. on Tuesday, 23 December 2025, to be held at the 24th Floor of Neptunus Yinhe Technology Mansion in Nanshan District, Shenzhen. The meeting aims to review and vote on the new Neptunus Group Sales Framework Agreement dated 30 October 2025 with Shenzhen Neptunus Group Company Limited.</p>\n<p>The agreement covers the sale of various self-manufactured or distributed products, including pharmaceutical products, healthcare food, and medical devices. Proposed sales caps for 2026, 2027, and 2028 will be presented for confirmation. The EGM will also consider authorizing a director to finalize and execute any additional documents or amendments related to the agreement.</p>\n<p>Interested shareholders, both holders of H shares and domestic shares, may attend and vote during the EGM subject to the applicable proxy and attendance procedures detailed in the official announcement. The final outcome of the proposed agreement and sales caps will be determined based on shareholder votes at the meeting.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"08329","symbol_name":"海王英特龙","start_time":0,"source_url":"","article_id":"1125119768","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1125119768","pubTimestamp":1763973870,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shenzhen Neptunus Interlong Bio-technique Company Limited (8329) has scheduled an extraordinary general meeting (EGM) at 10:00 a.m. on Tuesday, 23 December 2025, to be held at the 24th Floor of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"08329":"海王英特龙"},"translate_title":"深圳海王英特龙生物科技股份有限公司(8329)公布股东特别大会及销售框架协议建议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08329":1},"content_text":"Shenzhen Neptunus Interlong Bio-technique Company Limited (8329) has scheduled an extraordinary general meeting (EGM) at 10:00 a.m. on Tuesday, 23 December 2025, to be held at the 24th Floor of Neptunus Yinhe Technology Mansion in Nanshan District, Shenzhen. The meeting aims to review and vote on the new Neptunus Group Sales Framework Agreement dated 30 October 2025 with Shenzhen Neptunus Group Company Limited.\nThe agreement covers the sale of various self-manufactured or distributed products, including pharmaceutical products, healthcare food, and medical devices. Proposed sales caps for 2026, 2027, and 2028 will be presented for confirmation. The EGM will also consider authorizing a director to finalize and execute any additional documents or amendments related to the agreement.\nInterested shareholders, both holders of H shares and domestic shares, may attend and vote during the EGM subject to the applicable proxy and attendance procedures detailed in the official announcement. The final outcome of the proposed agreement and sales caps will be determined based on shareholder votes at the meeting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1125119768","isCrawlerRequest":true}